165 related articles for article (PubMed ID: 8794409)
1. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
Matsubara S; Yamaji Y; Fujita T; Kanayama T; Yamadori I; Sato M; Fujita J; Shiotani T; Takahara J
Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
[TBL] [Abstract][Full Text] [Related]
2. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy.
Polans AS; Witkowska D; Haley TL; Amundson D; Baizer L; Adamus G
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9176-80. PubMed ID: 7568096
[TBL] [Abstract][Full Text] [Related]
3. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision.
Bazhin AV; Shifrina ON; Savchenko MS; Tikhomirova NK; Goncharskaia MA; Gorbunova VA; Senin II; Chuchalin AG; Philippov PP
Lung Cancer; 2001 Oct; 34(1):99-104. PubMed ID: 11557119
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma.
Salgia R; Hedges TR; Rizk M; Reimer RH; Skarin AT
Lung Cancer; 1998 Nov; 22(2):149-52. PubMed ID: 10022222
[TBL] [Abstract][Full Text] [Related]
5. [Paraneoplastic retinopathy and anti-recoverin antibodies].
Bataller L; Graus F; Dalmau J
Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
[No Abstract] [Full Text] [Related]
6. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy.
Thirkill CE; Keltner JL; Tyler NK; Roth AM
Arch Ophthalmol; 1993 Jul; 111(7):931-7. PubMed ID: 8392327
[TBL] [Abstract][Full Text] [Related]
7. Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy.
Savchenko MS; Bazhin AV; Shifrina ON; Demoura SA; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2003 Sep; 41(3):363-7. PubMed ID: 12928127
[TBL] [Abstract][Full Text] [Related]
8. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
[TBL] [Abstract][Full Text] [Related]
9. Expression of a photoreceptor protein, recoverin, as a cancer-associated retinopathy autoantigen in human lung cancer cell lines.
Matsubara S; Yamaji Y; Sato M; Fujita J; Takahara J
Br J Cancer; 1996 Nov; 74(9):1419-22. PubMed ID: 8912538
[TBL] [Abstract][Full Text] [Related]
10. Invasive thymoma with paraneoplastic retinopathy.
Yamada G; Ohguro H; Aketa K; Itoh T; Shijubo N; Takahashi H; Fujiwara O; Satoh M; Ohtsuka K; Abe S
Hum Pathol; 2003 Jul; 34(7):717-9. PubMed ID: 12874770
[TBL] [Abstract][Full Text] [Related]
11. Pathological roles of recoverin in cancer-associated retinopathy.
Ohguro H; Nakazawa M
Adv Exp Med Biol; 2002; 514():109-24. PubMed ID: 12596918
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated retinopathy during treatment for small-cell lung carcinoma.
Kashiwabara K; Nakamura H; Kishi K; Yagyu H; Sarashina G; Kobayashi K; Matsuoka T
Intern Med; 1999 Jul; 38(7):597-601. PubMed ID: 10435368
[TBL] [Abstract][Full Text] [Related]
13. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
Ohguro H; Ogawa K; Nakagawa T
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
[TBL] [Abstract][Full Text] [Related]
14. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome.
Maeda A; Ohguro H; Nabeta Y; Hirohashi Y; Sahara H; Maeda T; Wada Y; Sato T; Yun C; Nishimura Y; Torigoe T; Kuroki Y; Sato N
Eur J Immunol; 2001 Feb; 31(2):563-72. PubMed ID: 11180121
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen.
Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
Arch Ophthalmol; 1993 Jul; 111(7):974-8. PubMed ID: 8392328
[TBL] [Abstract][Full Text] [Related]
16. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated retinopathy vs recoverin-associated retinopathy.
Keltner JL; Thirkill CE
Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
[No Abstract] [Full Text] [Related]
18. Cancer-associated retinopathy with presumed vasculitis.
Suzuki T; Obara Y; Sato Y; Saito G; Ichiwata T; Uchiyama T
Am J Ophthalmol; 1996 Jul; 122(1):125-7. PubMed ID: 8659589
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice.
Maeda A; Maeda T; Ohguro H; Palczewski K; Sato N
Eur J Immunol; 2002 Aug; 32(8):2300-7. PubMed ID: 12209643
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]